IGC Pharma, Inc. (IGC)

NYSEAMERICAN: IGC · Real-Time Price · USD

0.2628

+0.0025 (0.96%)

Feb 20, 2026, 12:04 PM EST - Market open

Revenue by Segment

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Life Sciences Segment	1.27M	1.35M	798.00K	359.00K	723.00K
Life Sciences Segment Growth	-5.50%	68.55%	122.28%	-50.35%	75.91%
Infrastructure Segment	-	-	113.00K	38.00K	175.00K
Infrastructure Segment Growth	-	-	197.37%	-78.29%	-95.22%
Total	1.27M	1.35M	911.00K	397.00K	898.00K
Total Growth	-5.50%	47.64%	129.47%	-55.79%	-77.95%

Revenue by Geography

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
United States of America	1.27M	1.18M	777.00K	329.00K	723.00K
United States of America Growth	7.63%	51.74%	136.17%	-54.50%	75.91%
Colombia	2.00K	2.00K	21.00K	-	-
Colombia Growth	0%	-90.48%	-	-	-
India	-	164.00K	113.00K	68.00K	175.00K
India Growth	-	45.13%	66.18%	-61.14%	62.04%
Total	1.27M	1.35M	911.00K	397.00K	898.00K
Total Growth	-5.50%	47.64%	129.47%	-55.79%	-77.95%

Source: S&P Global Market Intelligence.